feed,title,long_url,short_url
Benzinga,Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11,https://benzinga.com/general/biotech/21/02/19800182/sanofiregenerons-dupixent-wins-canada-approval-for-atopic-dermatitis-in-children-aged-6-11,
